Amedisys (AMED) Tops Q1 EPS by 21c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance
April 30, 2019 4:34 PM EDTBATON ROUGE, La., April 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2019.
Three Month Periods Ended March 31, 2019 and 2018
Net service revenue increased $68.0Â million to $467.3Â million compared to $399.3Â million in 2018.Net income attributable to Amedisys, Inc. of $31.3Â million compared to $27.2Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.95 per diluted share compared to $0.79 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $54.9Â million compared to $41.7Â million in 2018.Adjusted net service revenue of $467.8Â million compared to $399.3Â million in... More